HeyJaredKorin Miller
- Indexed articles, last 90 days
- 27
- Latest publication
- Sep 30, 2026
- Outlet visibility, for EverydayHealth.com
- Top 100K sites
- Earliest in this view
- Jul 8, 2026
Latest articles
Weight Loss Continues After Switching From a GLP-1 Shot to a Pill, Study Finds (opens the original)
Read excerpt
People using GLP-1 injections to treat obesity may at some point consider changing to a GLP-1 pill, which can be more affordable and possibly easier to manage. But there’s been limited research into whether the switch could derail someone’s weight loss progress. The study, which was presented at the annual meeting of the European Association for the Study of Diabetes, found that patients who switched from weekly injectable GLP-1 medications to the daily Wegovy pill lost 4.1 percent of their body
Onswik, a Once-a-Week Insulin Shot for Type 2 Diabetes, Gets FDA Approval (opens the original)
Read excerpt
Onswik is designed to deliver steady basal insulin over seven days, allowing people with type 2 diabetes to bypass daily injections. It is the second medication in its class. The first, Awiqli, received FDA approval in March 2026. “Weekly injections are advantageous because they greatly decrease the injection burden for patients,” says Jamie Alan, PharmD, PhD, an associate professor of pharmacology and toxicology at Michigan State University in East Lansing. The FDA’s approval is based on four r
GLP-1s Could Boost Health for Older Adults With Frailty as Well as Obesity (opens the original)
Read excerpt
For adults with obesity, weight loss from GLP-1 medications can yield numerous health benefits. But experts worry that weight loss that happens too rapidly can increase the likelihood of muscle loss — a risk that may be especially relevant for older adults with frailty who are already experiencing strength and mobility issues. The analysis challenges conventional thinking around GLP-1 use in this group. “There are persistent concerns around the balance of risk and benefit with GLP-1 receptor ago
Whole Grains May Lower Risk Factors for Heart Disease (opens the original)
Read excerpt
Many popular diets encourage people to minimize carbohydrates, but new research suggests this macronutrient can play an important role in heart health — when you choose whole grains. The data analysis found that adults who ate the most whole grains (up to six servings per day) had lower body weight, waist size, cholesterol, and blood sugar levels compared with similar adults who ate fewer whole grains — all important markers tied to heart disease risk. “Making whole grains a regular part of your
Menopausal Hormone Therapy May Protect Heart Health: Study (opens the original)
Read excerpt
The research found that hormone therapy reduced cardiovascular risk for women if they began taking it in the years leading up to menopause (perimenopause) and in the decade after menopause began, but not later. The study is the first of its kind to look at the impact of hormone therapy on cardiovascular disease risk during perimenopause, the life stage leading up to menopause, when estrogen levels begin to fluctuate. This transitional stage typically occurs during a woman’s forties and can last
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 100K sites
For EverydayHealth.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.